Open channel block of hKv1.5 by psoralen fromHeracleum moellendorffii hance (Archives of Pharmacal Research, (2005), 28, 3, (269-273), 10.1007/BF02977790);Open channel block of hKv1.5 by psoralen from Heracleum moellendorffii Hance

Archives of Pharmacal Research

Volumn 28, Issue 3, 2005, Pages 269-273

  Jae, Soon Eun ^a   Bok, Hee Choi ^b   Jeong, Ah Park ^b   Taek, Yul Lee ^a   Dae, Keun Kim ^a   Young, Hoon Jung ^c   Dong, Jin Yoo ^d   Yong, Geun Kwak ^b  

^a Woosuk University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Seonam University   (South Korea)

Author keywords

Heracleum moellendorffii hance; hKv1.5 channel blocker; Psoralen

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; KCNA5 PROTEIN, HUMAN; KCNA5 PROTEIN, MOUSE; KCNA5 PROTEIN, RAT; PLANT EXTRACT; POTASSIUM CHANNEL KV1.5; PSORALEN DERIVATIVE; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEART; HERACLEUM; HUMAN; IN VITRO STUDY; MOUSE; PATCH CLAMP; PHYSIOLOGY; RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HERACLEUM; HUMANS; KV1.5 POTASSIUM CHANNEL; MICE; PATCH-CLAMP TECHNIQUES; PLANT EXTRACTS; POTASSIUM CHANNELS, VOLTAGE-GATED; PSORALENS; RATS;

EID: 23344439428     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02969367     Document Type: Erratum

References (21)

1. Carneiro, L. V., Ferreira, S. R., Chen, C. L., and Andreu, G. L., Psoralen derivatives and longwave ultraviolet irradiation are activie in vitro against human melanoma cell line. J. Photochem. Photobiol. B, 76, 49-53 (2004).
2. Colatsky, T. J., Follmer, C. H., and Starmer, C. F., Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation, 82, 2235-2242 (1990).
3. Damjanovich, S., Gaspar, R., and Panyi, G., An alternative to conventional immunosuppression: small- molecule inhibitors of Kv1.3 channels. Mol. Interv., 4, 250-254 (2004).
4. + channel gating: cloned delayed rectifier mechanisms and drug modulation. Can. J. Physiol. Pharmacol., 76, 77-89 (1998).
5. Kostovic, K., Nola, I., Bucan, Z., and Situm, M., Treatment of vitiligo: current methods and new approaches. Acta. Dermatovenerol Croat., 11, 163-170 (2003).
6. + channel function by the Kvbeta 1.3 subunit. J. Biol. Chem., 274, 25355-25361 (1999).
7. Mariano, T. M., Vetrano, A. M., Gentile, S. L., Heck, D. E., Whittemore, M. S., and Guillon, C. D., Cell-impermeant pyridinium derivatives of psoralens as inhibitors keratinocyte growth. Biochem. Pharmacol., 3, 31-39 (2002).
8. Matsumoto, H. and Ohkura, Y., Studies of the absorption spectra of some psoralens. Chem. Pharm. Bull., 26, 3433-3437 (1978).
9. Nakano, Y., Matsunaga, H., Saita, T., Mori, M., Katano, M., and Okabe, H., Anitproliferative constituents in Umbelliferae plants II. Screening for polyacetylenes in some Umbelliferae plants, and isolation of panaxynol and falcarindiol from the root of Heracleum moellendorffii. Biol. Pharm. Bull., 21, 257-261 (1998).
10. Roden, D. M., Current status of class III antiarrhythmic drug therapy. Am. J. Cardiol., 72, 44B-49B (1993).
11. Roden, D. M., Mechanism and management of proarrhythmia. Am. J. Cardiol., 82, 491-571 (1998).
12. Roden, D. M. and George, A. J. Jr., The cardiac ion channel: relevance to management of arrhythmias. Annu. Rev. Med., 47, 138-148 (1999).
13. Sanguinetti, M. C. and Keating, M. T., Role of delayed rectifier potassium channels in cardiac repolarization and arrhythmias. News Physiol. Sci., 12, 152-157 (1997).
14. Smith, M. L., Gregory, P., Bafi-Yeboa, N. F., and Arnason, J. T., Inhibition of DNA polymerization and antifungal specificity of furanocoumarins present in traditional medicines. Photochem. Photobiol., 79, 506-509 (2004).
15. Snyders, D. J., Knoth, K. M., Roberts, S. L., and Tamkun, M. M., Time-, voltage, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol. Pharmacol., 41, 322-330 (1992).
16. Snyders, D. J., Tamkun, M. M., and Bennett, P. B., A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J. Gen. Physiol., 101, 513-543 (1993).
17. Vaughan-Williams, E. M., Classification of antiarrhythmic actions. In: Vaughan-Willims EM, ed. Handbook of Experimental Pharmacology, 89, 45-62 (1989).
18. + current similar to Kv1.5 cloned channel currents. Circ. Res., 73, 1061-1076 (1993).
19. Wang, Z., Fermini, B., and Nattel, S., Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc. Res., 28, 1540-1546 (1994).
20. Wu, S. J., Li, D. Y., Zhang, L., Du, X. D., and Zhang, Y. K., Studies on the coumarins from the zou-ma-qin (Heracleum moellendorffii Hance var. Paucivitatum). Yao Xue Xue Bao., 21, 599-604 (1986).
21. Zhang, H. Q., Studies on the coumarin of root of Heracleum moellendorffii Hance. Zhong Yao Tong Bao., 6, 27-29 (1981).